Author

Alice Tsang Shaw

Harvard UniversityORCID 0000-0001-6337-1093Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:variant calling· 2 Assay:whole-exome sequencing· 2 Assay:bulk RNA-seq· 1 Research Focus:trajectory inference· 1

Frequent Co-Authors

Chip StewartiD· 2 shared Gad A. GetziD· 2 shared Ignaty LeshchineriD· 2 shared Jaegil KimiD· 2 shared Justin F. GainoriD· 2 shared Mari A. Mino-KenudsoniD· 2 shared Aaron Timothy GriffiniD· 1 shared Aina Zurita MartineziD· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Chip StewartORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintMar 21, 2022

Integrative Analysis of Checkpoint Blockade Response in Advanced Non-Small Cell Lung Cancer

Arvind Ravi, Justin F. Gainor, Monica B. Arniella…·Matthew David Hellmann

This study identifies molecular and immune features associated with response to anti-PD-(L)1 therapy in NSCLC using a cohort of 393 patients.

1 citation

humanwhole-exome sequencing

𝕏 PostBluesky

BioinformaticsbioRxivPreprintFeb 16, 2019

Comprehensive analysis of tumour initiation, spatial and temporal progression under multiple lines of treatment

Ignaty Leshchiner, Dimitri G. Livitz, Justin F. Gainor…·Gad A. Getz

PhylogicNDT statistically reconstructs cancer driver timing, subclonal phylogenies, and population dynamics from single- or multi-timepoint sequencing, revealing subtype-specific trajectories and therapy resistance evolution across 498 lung adenocarcinomas.

79 citations

humanwhole-exome sequencing

𝕏 PostBluesky